# Nevirapine Dosing in Neonates for Prophylaxis of Mother-to-Child-Transmission (MTCT) of HIV Infection

> **NCT02166502** · — · COMPLETED · sponsor: **The Hospital for Sick Children** · enrollment: 27 (actual)

## Conditions studied

- Human Immunodeficiency Virus
- HIV
- Vertical Infection Transmission

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02166502
- **Lead sponsor:** The Hospital for Sick Children
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2015-05
- **Final completion:** 2015-11
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2015-11-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02166502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02166502, "Nevirapine Dosing in Neonates for Prophylaxis of Mother-to-Child-Transmission (MTCT) of HIV Infection". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02166502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*